68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

May 5, 2021

Study Completion Date

April 6, 2022

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

68Ga-PSMA-11 PET/MRI

The PET/MRI exam-related patient visit will last approximately 2 to 2.5 hours, including 30-minute nursing assessment, 45-60 minutes for PSMA uptake and 60 minutes for PET/MRI scan. They will be contacted within the next 72 hours to complete a brief phone survey.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

All Listed Sponsors
lead

Ajit H. Goenka, MD

OTHER

NCT03982407 - 68 Ga PSMA PET/MRI for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter